Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease

Jing-Lu Jin,Hui-Wen Zhang,Ye-Xuan Cao,Hui-Hui Liu,Qi Hua,Yan-Fang Li,Yan Zhang,Yuan-Lin Guo,Na-Qiong Wu,Cheng-Gang Zhu,Rui-Xia Xu,Ying Gao,Chuan-Jue Cui,Geng Liu,Jing Sun,Qian Dong,Jian-Jun Li
DOI: https://doi.org/10.1007/s12072-021-10167-w
IF: 9.029
2021-03-19
Hepatology International
Abstract:Although non-invasive liver fibrosis scores (LFSs) have already been considered as effective tools for estimating cardiovascular risk, their roles in predicting disease severity and cardiovascular event (CVEs) in patients with stable coronary artery disease (CAD) are not comprehensively evaluated. The aim of the present study was to investigate whether non-alcoholic fatty liver disease fibrosis score (NAFLD-FS) and fibrosis-4 (FIB-4) are associated with CVEs in a large cohort with long-term follow-up.
gastroenterology & hepatology
What problem does this paper attempt to address?